How did the Polynovo share price respond last time the company reported?

Polynovo shares will be on watch tomorrow as the company reports its earnings. Let's look back to see what happened last time.

| More on:
Two happy scientists analysing test results in a lab

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price is having a pretty pleasing day of trade this Thursday. At present, Polynovo shares are up an encouraging 2% at $2.04 each.

That compares well against the S&P/ASX 200 Index (ASX: XJO), which is also in the green, but by 0.76% at about 7,051 points. So a market-beating kind of day for Polynovo shares.

But today is just a warm-up act. Because all eyes will be on this ASX healthcare company tomorrow when it reports its full-year earnings for the 2022 financial year.

Now, we obviously can't predict what is going to happen to Polynovo shares tomorrow from where we stand today. They could go up, go down, or stay flat. But what we can do is take a look at what happened to the Polynovo share price the last time this company reported earnings.

What happened to the Polynovo share price last earnings season?

So Polynovo's last reporting date with ASX investors was back on 25 February of this year. That was when the company dropped its half-year results for FY2022, which covered the six months to 31 December 2021.

As we covered at the time, the company reported a 41.9% surge in revenue to $18.15 million. That led to Polynovo announcing an underlying profit after tax of $1.618 million. That was up from the previous year's loss of $3.57 million.

However, the company still reported a net loss after tax of $1.7 million when non-cash items were excluded.

So how did Polynovo shares react to these earnings? Well, it was an interesting tale.

Upon the release of this report on Friday 25 February, the Polynovo share price ended the trading day with a loss of 3.77%. The following Monday saw the company lose another 1.96%, but the next day the company gained an impressive 10%.

Now this experience in no way tells us what exactly will happen with the Polynovo share price tomorrow. If the results are above the market's expectations, the shares will, in all likelihood, go up. If they are below expectations, the shares might fall. But it's still an interesting insight into what can happen during earnings season.

At the current Polynovo share price, this ASX 200 healthcare share has a market capitalisation of $1.35 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »